fosamprenavir
Generic: FOSAMPRENAVIR CALCIUM·Brand: FOSAMPRENAVIR CALCIUM, LEXIVA, Lexiva
fosamprenavir: 1 clinical trial tracked.
fosamprenavir evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about fosamprenavir, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (1)
Efficacy and Safety of Regimens Restricted to a Combination of Two Boosted Protease Inhibitors as Potent Antiretroviral Therapy in HIV-1 Infected Patients. ANRS 127 2IP
Primary endpoint: Virologic success defined as HIV RNA levels below 50 copies/ml after 16 weeks of initial treatment
InterventionalRandomizedopen61 enrolledStarted 2005-12Completion 2007-081 site · FranceFrench National Agency for Research on AIDS and Viral Hepatitis